Now Open  ·  Accepting New Patients
Schedule an Appointment Pay My Bill
321-400-3214
Menopause Education  ·  Winter Garden, FL

Menopausal hormone therapy:
weighing benefits and risks.

Hormone therapy can be highly effective for hot flashes and other menopause symptoms, but it isn't automatically right for everyone. Here's how the decision is typically weighed.

Schedule a Visit Explore Menopause Care
Quick answer

Hormone therapy is FDA-approved and often effective for bothersome hot flashes, night sweats, and related symptoms. For many healthy women who start it before age 60 or within 10 years of their final period, the potential benefits can outweigh the risks. For women who start later, or who have certain health histories, the balance can shift, which is why the decision is made individually with a clinician rather than as a blanket recommendation.

The details

How the balance
is actually weighed.

Hormone therapy replaces some of the estrogen, and often progestogen, that the body stops producing around menopause. It's considered the most effective treatment for bothersome hot flashes, night sweats, and genitourinary symptoms like vaginal dryness, and it can also help protect bone density. For many women, that makes it a genuinely helpful option, but "effective" isn't the same as "right for everyone."

Timing matters. For women younger than 60, or within about 10 years of their final period, without contraindications, the benefit-risk ratio is generally considered favorable for treating symptoms and protecting bone health. For women who start hormone therapy more than 10 years after menopause, or after age 60, the balance tends to shift, because the absolute risks of things like heart disease, stroke, blood clots, and dementia increase with age regardless of hormone use, and starting therapy later doesn't carry the same favorable window.

Risk also depends on the specifics: the type of hormone therapy, the dose, how it's taken (pill versus patch or gel), how long it's used, and whether a progestogen is included. Transdermal options and lower doses may carry a different risk profile for some patients, particularly around blood clot and stroke risk. Personal and family health history matters too, including any history of certain cancers, blood clots, or cardiovascular disease. None of this is meant to be assessed alone. A clinician reviews your specific situation and walks through what applies to you.

Source: The Menopause Society

What your clinician reviews

What goes into
the decision.

Hormone therapy decisions are individualized. These are the main factors that shape the conversation.

Our approach

How Dr. Luciano
approaches this decision.

There's no default prescription. The goal is a therapy, or a non-hormonal alternative, matched to your specific situation.

01
A full history and risk review
Your symptoms, age, timing since menopause, and personal and family health history, reviewed together before any recommendation.
02
A therapy matched to you
If hormone therapy is appropriate, the type, dose, and route are chosen for your specific risk profile and goals, not a one-size prescription.
03
Ongoing reevaluation
Benefits and risks are revisited periodically rather than treated as a permanent, unreviewed decision.
Related reading
Hormone Therapy FAQ

Common
questions.

Is hormone therapy safe?+
It depends on the person. Hormone therapy is FDA-approved and, for many healthy women who start it before age 60 or within 10 years of their last period, the potential benefits can outweigh the risks. For women who start later, or who have certain personal or family health history, the balance can shift. Safety is assessed individually, not as a blanket yes or no.
Who is generally a good candidate for hormone therapy?+
Women with bothersome hot flashes, night sweats, or related symptoms who are under 60 or within about 10 years of their final period, and who don't have certain contraindications, are often considered good candidates. A clinician will review your full history before making a recommendation.
Who might hormone therapy not be right for?+
Hormone therapy may carry more risk for women who start it more than 10 years after their final period or after age 60, and for those with certain personal or family histories, such as some clotting disorders, certain cancers, or specific cardiovascular conditions. Your clinician can review your history and explain whether these apply to you.
Does the type of hormone therapy matter?+
Yes. Risk can vary by the type, dose, duration, and route of hormone therapy, and by whether a progestogen is included. Transdermal options, like patches or gels, and lower doses may carry a different risk profile than oral forms for some patients. This is one of the things a clinician tailors to you.
Does hormone therapy increase breast cancer risk?+
The relationship between hormone therapy and breast cancer risk depends on the type of hormone therapy, how long it's used, and your individual risk factors. This is one of the most important things to discuss with your clinician, who can put your personal risk in context rather than relying on a general statistic alone.
How long can someone stay on hormone therapy?+
There's no single universal time limit. Duration is individualized and typically reevaluated periodically, weighing your current symptoms, age, and health status. Some women use it for a few years, others longer, based on an ongoing conversation with their clinician.

Ready for healthcare
that's actually for you?

Schedule your first visit with Dr. Luciano today — unhurried appointments, direct answers, and care built around you from day one.

We intentionally maintain an unhurried schedule so every patient receives the time and attention she deserves.

Schedule an Appointment